Searchable abstracts of presentations at key conferences in endocrinology

ea0026p62 | Endocrine tumours and neoplasia | ECE2011

Injection systems for long-acting somatostatin analogs: a comparative assessment of preparation times and nurses' perceptions

Adelman D T , Burgess A , Davies P R

Introduction: The two major long-acting somatostatin analogues (SSA) available on the European market for the treatment of neuroendocrine tumours and acromegaly are Somatuline Autogel (SA) and Sandostatin LAR (LAR). The aim of this study was to gain nurses’ insights on the use and ease of administration of SSA devices, including Somatuline Autogel new device (SA-ND), in Europe and the US.Methods/design: Seventy-seven qualified nurses with ≥3 S...

ea0024op1.4 | (1) | BSPED2010

Differences in metabolic effects of twice daily versus multiple daily insulin injections in children with type 1 diabetes

Abid N , Buckley G , Porter L , Day E , Davies P , Shaw N , Kirk J , Krone N , Hogler W , Barrett T

Introduction: Two insulin regimes are commonly used in type 1 diabetes (T1D): twice daily (BD) premixed insulin (short and intermediate acting), and multiple daily injections (MDI) of short acting insulin with once daily bolus of long acting insulin. MDI is associated with better glucose control in adults, but the evidence base is weaker for children.Objectives: We aimed to compare children started on MDI to BD from diagnosis, on HbA1c as a measure of gl...